Furthermore, Zhang et al. indicated that knockdown of TPX2 repressed the tumor epithelial-mesenchymal transition (EMT) to inhibit tumor growth via ERK/GSK3β/SNAIL signaling pathway in prostate cancer [33]. The gene discussed is TPX2; the disease is prostate carcinoma.